Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Psychiatr Serv ; 72(1): 100-103, 2021 01 01.
Article in English | MEDLINE | ID: covidwho-1059742

ABSTRACT

Because of the COVID-19 pandemic, many mental health care services have been shifted from face-to-face to virtual interactions. Several health policy changes have influenced telehealth uptake during this time, including changes in technology, Internet connectivity, prescriptions, and reimbursement for services. These changes have been implemented for the duration of the pandemic, and it is unclear if all, some, or none of these new or amended policies will be retained after the pandemic has ended. Accordingly, in the wake of changing policies, mental health care providers will need to make decisions about the future of their telehealth programs. This article briefly reviews telehealth policy changes due to the COVID-19 pandemic and highlights what providers should consider for future delivery and implementation of their telehealth programs.


Subject(s)
COVID-19 , Drug Prescriptions , Insurance, Health , Mental Health Services , Telemedicine , Continuity of Patient Care , Drug Prescriptions/standards , Humans , Insurance, Health/legislation & jurisprudence , Insurance, Health/organization & administration , Insurance, Health/standards , Insurance, Health, Reimbursement/legislation & jurisprudence , Insurance, Health, Reimbursement/standards , Mental Health Services/legislation & jurisprudence , Mental Health Services/organization & administration , Mental Health Services/standards , Telemedicine/legislation & jurisprudence , Telemedicine/organization & administration , Telemedicine/standards , United States
2.
Fertil Steril ; 114(6): 1126-1128, 2020 12.
Article in English | MEDLINE | ID: covidwho-959775

ABSTRACT

Telemedicine had been very slowly making inroads into standard clinical practice. The onset of the COVID-19 pandemic resulted in the rapid implementation of telemedicine across most practices. The efficiency and permanence of telemedicine services depends on a multitude of factors including technologic choices, governmental and insurance regulations, reimbursement policies, and staff and patient education and acceptance. Although challenges remain and the extent of implementation is still evolving, it is clear that telemedicine is here to stay and that all those involved in health care need to be familiar with its opportunities and challenges.


Subject(s)
COVID-19 , Reproductive Medicine , SARS-CoV-2 , Telemedicine , Health Insurance Portability and Accountability Act , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Office Visits/economics , Office Visits/trends , Patient Education as Topic , Personnel Staffing and Scheduling , Reproductive Medicine/instrumentation , Reproductive Medicine/methods , Reproductive Medicine/trends , Telemedicine/instrumentation , Telemedicine/methods , Telemedicine/trends , United States
3.
J Vasc Surg ; 72(6): 1856-1863, 2020 12.
Article in English | MEDLINE | ID: covidwho-863661

ABSTRACT

Although the coronavirus disease 2019 (COVID-19) pandemic has created havoc with the U.S healthcare system and physicians, the financial and contractual implications for physicians are now beginning to come to the forefront. Financial assistance from the federal government has mainly been received by hospitals, which have borne the brunt of the COVID-19 illness. Some physician groups have, or are, receiving assistance through a few programs, although the accelerated and advance payments have been suspended. Employed surgeons are now being furloughed, terminated, or persuaded to agree to a significant cut in pay, forego bonuses, or take leave without pay as healthcare systems and some physician groups have started to experience the consequences of halting elective procedures. Newly hired surgeons might be forced in a few cases to agree to delays in starting their employment, new amendments, changes in employment status, and other terms for fear of losing their employment. In the present report, we have explained some agreement terminology and options available to allow physicians to understand the terms of their employment agreement and make their decisions after consulting with an expert healthcare attorney.


Subject(s)
COVID-19/economics , Employment/economics , Financing, Government/economics , Income , Insurance, Health, Reimbursement/economics , Surgeons/economics , Ambulatory Care/economics , COVID-19/legislation & jurisprudence , Employment/legislation & jurisprudence , Financing, Government/legislation & jurisprudence , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Policy Making , Practice Management, Medical/economics , Surgeons/legislation & jurisprudence , Telemedicine/economics , Time Factors , United States
5.
J Vasc Surg ; 72(4): 1161-1165, 2020 10.
Article in English | MEDLINE | ID: covidwho-133517

ABSTRACT

The appropriate focus in managing the COVID-19 pandemic in the United States has been addressing access and delivery of care to the population affected by the outbreak. All sectors of the U.S. economy have been significantly affected, including physicians. Physician groups of all specialties and sizes have experienced the financial effects of the pandemic. Hospitals have received billions of dollars to support and enable them to manage emergencies and cover the costs of the disruption. However, many vascular surgeons are under great financial pressure because of the postponement of all nonemergency procedures. The federal government has announced a myriad of programs in the form of grants and loans to reimburse physicians for some of their expenses and loss of revenue. It is more than likely that unless the public health emergency subsides significantly, many practices will experience dire consequences without additional financial assistance. We have attempted to provide a concise listing of such programs and resources available to assist vascular surgeons who are small businesses in accessing these opportunities.


Subject(s)
Appointments and Schedules , Compensation and Redress , Coronavirus Infections/economics , Elective Surgical Procedures/economics , Income , Insurance, Health, Reimbursement/economics , Pandemics/economics , Pneumonia, Viral/economics , Surgeons/economics , Vascular Surgical Procedures/economics , COVID-19 , Compensation and Redress/legislation & jurisprudence , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/therapy , Elective Surgical Procedures/legislation & jurisprudence , Financing, Government/economics , Financing, Government/legislation & jurisprudence , Health Services Needs and Demand/economics , Health Services Needs and Demand/legislation & jurisprudence , Humans , Insurance, Health, Reimbursement/legislation & jurisprudence , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/therapy , Policy Making , Surgeons/legislation & jurisprudence , United States/epidemiology , Vascular Surgical Procedures/legislation & jurisprudence
SELECTION OF CITATIONS
SEARCH DETAIL